GlassScriptAlinity
Payments companies reported to CMS as associated with Alinity. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Alinity, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Alinity
These are the largest totals companies reported as associated with Alinity. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Welch | Detroit, MI | Emergency Medicine | $21,522.48 |
| Jeffrey Bazarian | Rochester, NY | Physical Medicine & Rehabilitation | $15,440.33 |
| James Januzzi | Boston, MA | Cardiovascular Disease | $14,427.60 |
| Kevin Holcomb | New York, NY | Gynecologic Oncology | $13,000.00 |
| Jesse Ehrenfeld | Milwaukee, WI | Anesthesiology | $10,596.00 |
| Mrinalini Kulkarni | Austin, TX | Endocrinology, Diabetes & Metabolism | $10,557.71 |
| Ambarish Pandey | Dallas, TX | Cardiovascular Disease | $10,133.87 |
| Angela Goepferd | Minneapolis, MN | Pediatrics | $9,800.00 |
| David Mcclintock | Ann Arbor, MI | Anatomic Pathology & Clinical Pathology | $9,096.00 |
| Stephen Master | Philadelphia, PA | Clinical Pathology/Laboratory Medicine | $9,096.00 |
Prescribed Alinity?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.